Measurement and assessment of grief in a large international sample.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
14 04 2023
Historique:
received: 09 08 2022
revised: 17 01 2023
accepted: 25 01 2023
pubmed: 4 2 2023
medline: 3 3 2023
entrez: 3 2 2023
Statut: ppublish

Résumé

In 2022, the International Classification of Diseases (ICD-11) and an update of the Diagnostic Statistical Manual of Mental Disorders (DSM 5 TR) were released for implementation worldwide and now include the new Prolonged Grief Disorder (PGD). The newest definition of PGD is based on robust clinical research from the Global North yet until now has not been tested for global applicability. The current study assesses the new PGD ICD-11 criteria in a large international sample of 1393 bereaved adults. The majority of the sample was included from the USΑ. Additionally, we conduct a sub-sample analysis to evaluate the psychometric properties, probable caseness of PGD, and differences in network structure across three regions of residency (USA, Greece-Cyprus, Turkey-Iran). The psychometric validity and reliability of the 33-item International Prolonged Grief Disorder Scale (IPGDS) were confirmed across the whole sample and for each regional group. Using the strict diagnostic algorithm, the probable caseness for PGD for the whole sample was 3.6 %. Probable caseness was highest for the Greece-Cyprus group (6.9 %) followed by Turkey-Iran (3.2 %) and the USA (2.8 %). Finally, the network structure of the IPGDS standard items and cultural supplement items (total of 33 items) confirmed the strong connection between central items of PGD, and revealed unique network connections within the regional groups. Future research is encouraged to include larger sample sizes and a more systematic assessment of culture. Overall, our findings confirm the global applicability of the new ICD-11 PGD disorder definition as evaluated through the newly developed IPGDS. This scale includes culturally sensitive grief symptoms that may improve clinical precision and decision-making.

Sections du résumé

BACKGROUND
In 2022, the International Classification of Diseases (ICD-11) and an update of the Diagnostic Statistical Manual of Mental Disorders (DSM 5 TR) were released for implementation worldwide and now include the new Prolonged Grief Disorder (PGD). The newest definition of PGD is based on robust clinical research from the Global North yet until now has not been tested for global applicability.
METHODS
The current study assesses the new PGD ICD-11 criteria in a large international sample of 1393 bereaved adults. The majority of the sample was included from the USΑ. Additionally, we conduct a sub-sample analysis to evaluate the psychometric properties, probable caseness of PGD, and differences in network structure across three regions of residency (USA, Greece-Cyprus, Turkey-Iran).
RESULTS
The psychometric validity and reliability of the 33-item International Prolonged Grief Disorder Scale (IPGDS) were confirmed across the whole sample and for each regional group. Using the strict diagnostic algorithm, the probable caseness for PGD for the whole sample was 3.6 %. Probable caseness was highest for the Greece-Cyprus group (6.9 %) followed by Turkey-Iran (3.2 %) and the USA (2.8 %). Finally, the network structure of the IPGDS standard items and cultural supplement items (total of 33 items) confirmed the strong connection between central items of PGD, and revealed unique network connections within the regional groups.
LIMITATIONS
Future research is encouraged to include larger sample sizes and a more systematic assessment of culture.
CONCLUSION
Overall, our findings confirm the global applicability of the new ICD-11 PGD disorder definition as evaluated through the newly developed IPGDS. This scale includes culturally sensitive grief symptoms that may improve clinical precision and decision-making.

Identifiants

pubmed: 36736540
pii: S0165-0327(23)00113-1
doi: 10.1016/j.jad.2023.01.095
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

306-314

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors report no conflict of interest.

Auteurs

C Killikelly (C)

University of Zurich, Switzerland; University of British Columbia, Canada. Electronic address: c.killikelly@psychologie.uzh.ch.

A Kagialis (A)

Department of Psychiatry, School of Medicine, University of Crete, Heraklion, Greece.

S Henneman (S)

Johannes Gutenberg University Mainz, Germany. Electronic address: s.hennemann@uni-mainz.de.

H Coronado (H)

University of Arizona, USA. Electronic address: haleyacoronado@email.arizona.edu.

D Demanarig (D)

University of Bridgeport, USA. Electronic address: ddemanar@bridgeport.edu.

H Farahani (H)

Tarbiat Modares University, Iran. Electronic address: h.farahani@modares.ac.ir.

A A Özdoğru (AA)

Üsküdar University, Turkey. Electronic address: asil.ozdogru@uskudar.edu.tr.

B Yalçın (B)

Üsküdar University, Turkey.

A Yockey (A)

University of North Texas Health Science Center, Department of Biostatistics and Epidemiology, USA. Electronic address: robert.yockey@unthsc.edu.

C L Gosnell (CL)

Pace University, USA. Electronic address: cgosnell@pace.edu.

F Jia (F)

Seton Hall University, USA. Electronic address: fanli.jia@shu.edu.

M Maisel (M)

Mount St Mary's University, USA. Electronic address: mem30@hood.edu.

E Stelzer (E)

University of Arizona, USA.

D Wilson (D)

University of Arizona, USA. Electronic address: damerewilson@email.arizona.edu.

J Anderson (J)

Southeastern University, USA.

K Charles (K)

Pace University, USA. Electronic address: kc37497p@pace.edu.

J P Cummings (JP)

Southeastern University, USA. Electronic address: jpcummings@seu.edu.

C Faas (C)

Mount St Mary's University, USA. Electronic address: caitlin@drcaitlinfaas.com.

B Knapp (B)

Southeastern University, USA.

B Koneczny (B)

Minnesota State Moorhead, USA. Electronic address: brenda.koneczny@mnstate.edu.

C Koch (C)

George Fox University, USA. Electronic address: ckoch@georgefox.edu.

L M Bauer (LM)

University of Missouri, USA. Electronic address: bauerlm@missouri.edu.

C Cuccolo (C)

Alma College, Alma, MI, USA. Electronic address: cuccolokm@alma.edu.

J E Edlund (JE)

Rochester Institute of Technology, USA. Electronic address: jeegsh@rit.edu.

G F Heermans (GF)

University of Vermont, USA. Electronic address: Gabriela.Heermans@uvm.edu.

S McGillivray (S)

Weber State University, USA. Electronic address: smcgillivray@weber.edu.

C Shane-Simpson (C)

University of Wisconsin Stout, USA.

A Staples (A)

Weatherford College, USA. Electronic address: astaples@wc.edu.

Z Zheng (Z)

Lasell University, USA. Electronic address: zzheng@lasell.edu.

M S Zlokovich (MS)

Psi Chi, the International Honor Society in Psychology, USA. Electronic address: martha.zlokovich@psichi.org.

M S Irgens (MS)

University of Arizona, USA. Electronic address: meganirgens@email.arizona.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH